Table 2. Number of cells in individual training and target data subsets and total number of cells for each of the six datasets for the 5-fold cross-validation evaluation approach.

Dataset	Number of Training Cells	Number of Target Cells	Total Number of Cells
PBMC Hao	1,000	4,000	5,000
	2,500	10,000	12,500
	5,000	20,000	25,000
	10,000	40,000	50,000
	12,000	48,000	60,000
PBMC Unterman	1,000	4,000	5,000
	2,500	10,000	12,500
	5,000	20,000	25,000
	10,000	40,000	50,000
MALT	1,000	4,000	5,000
	1,250	5,000	6,250
	1,500	6,000	7,500
	1,682	6,728	8,410
Monocytes	7,422	29,690	37,112
MPEM	994	3,975	4,969
Spleen and Lymph Nodes	3,940	15,758	19,698